MAPT and Cognitive impairment: In Alzheimer's disease characterized by neuro loss and cognitive impairment, TPNS can protect nerves by targeting circRNA expression, regulating brain metabolism-related pathways, regulating mitochondrial proteins, and inhibiting tau protein phosphorylation [13, 25–27].